Tom Brady opens up about his health amid GLP-1 surge: Water, movement and discipline
eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss the growth of the GLP-1 market and the company’s latest funding round on ‘Morning with Maria.’ As the market for GLP-1 weight loss drugs exploded to an estimated $150 billion, NFL legend Tom Brady stepped into the arena – not to promote a … Read more